Biotech companies by P/S ratio

Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.

CG Oncology leads the 19 biotech companies ranked by P/S ratio, at 1753, ahead of CRISPR Therapeutics (1130) and Kymera Therapeutics (265). Figures as of 18 Nov 2026, 19:17 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
19
First
CG Oncology1753
Median
14.3
Combined market value
AED 3.07T
Countries
5
Not ranked
5no P/S ratio on file

Market values as of .

All countries
All sectors
Biotech
AED
Clear filters
Biotech companies by P/S ratio
#CompanyP/S ↓Market capPriceToday1 yearPrice, 30 daysCountry
1CG OncologyCGON · Health Care1753AED 26BAED 291.18 0.44% up 85% up United States
2CRISPR TherapeuticsCRSP · Health Care1130AED 14.6BAED 150.21 1.87% up 21% down Switzerland
3Kymera TherapeuticsKYMR · Health Care265AED 38.1BAED 446.37 0.02% up 87% up United States
4ImmunityBioIBRX · Health Care62.0AED 25.8BAED 24.24 5.43% up 193% up United States
5ModernaMRNA · Health Care41.5AED 296.1BAED 731.82 3.64% down 755% up United States
6Krystal BiotechKRYS · Health Care23.8AED 34BAED 1,149.01 4.79% up 46% up United States
7Twist BioscienceTWST · Health Care21.4AED 29.5BAED 433.40 5.37% up 340% up United States
8Adaptive BiotechnologiesADPT · Health Care16.7AED 17BAED 105.22 0.56% up 88% up United States
9RepligenRGEN · Health Care14.9AED 40.3BAED 630.92 5.93% up 5% up United States
10argenxARGX · Health Care14.3AED 218.3BAED 3,471.19 0.25% down 4% up Belgium
11Bio-TechneTECH · Health Care9.4AED 42BAED 267.27 0.20% up 26% up United States
12Halozyme TherapeuticsHALO · Health Care7.9AED 40.3BAED 353.25 0.22% up 37% up United States
13ExelixisEXEL · Health Care7.2AED 61.6BAED 252.34 0.31% up 63% up United States
14Gilead SciencesGILD · Health Care7.1AED 768.4BAED 619.53 0.92% down 33% up United States
15BioNTechBNTX · Health Care6.5AED 76.3BAED 307.86 1.22% down 16% down Germany
16AmgenAMGN · Health Care6.5AED 880.2BAED 1,627.33 3.24% down 34% up United States
17Neurocrine BiosciencesNBIX · Health Care5.8AED 60.8BAED 600.91 1.39% down 20% up United States
18QiagenQGEN · Health Care4.9AED 37.7BAED 182.51 0.11% down 12% up Netherlands
19BiogenBIIB · Health Care3.7AED 136BAED 920.19 0.09% down 49% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. P/S divides today's market value by the latest fiscal year's revenue from the annual report. Sums are converted from US dollars at today's exchange rate (1 USD = 3.6726 AED). 5 companies have no P/S ratio on file and are not ranked here.

Questions and answers

Which biotech companies rank first by P/S ratio?

CG Oncology (1753), CRISPR Therapeutics (1130) and Kymera Therapeutics (265) are the top three of the 19 biotech companies ranked by P/S ratio as of 18 Nov 2026, 19:17 UTC.

How many biotech companies are in this ranking?

19 are ranked by P/S ratio. 5 more have no P/S ratio on file and are left out rather than ranked at zero.

What are these biotech companies worth together?

The 19 biotech companies ranked by P/S ratio have a combined market value of AED 3.07T as of 18 Nov 2026, 19:17 UTC.

What does ranking by P/S ratio measure?

Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.

Cite this page

Funkfolio, “Biotech companies by P/S ratio”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=ps-ratio

Underlying data: Yahoo Finance; SEC EDGAR.